Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead
Despite the recent advances in the diagnosis of tuberculosis, treatment of the disease, for the most part, remains the same as it was half a century ago. In recent years only two new anti-tuberculosis drugs have been approved by the European Medicines Agency and Food and Drug Administration. Though...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2016-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1010660X16000203 |
| _version_ | 1797717209453166592 |
|---|---|
| author | Greta Musteikienė Skaidrius Miliauskas Raimundas Sakalauskas Astra Vitkauskienė Marius Žemaitis |
| author_facet | Greta Musteikienė Skaidrius Miliauskas Raimundas Sakalauskas Astra Vitkauskienė Marius Žemaitis |
| author_sort | Greta Musteikienė |
| collection | DOAJ |
| description | Despite the recent advances in the diagnosis of tuberculosis, treatment of the disease, for the most part, remains the same as it was half a century ago. In recent years only two new anti-tuberculosis drugs have been approved by the European Medicines Agency and Food and Drug Administration. Though the prevalence of this disease is slowly decreasing all over Europe, new challenges appear. One of them is multidrug-resistant tuberculosis (MDR-TB). This problem is especially prominent in Lithuania, which is one of the 27 high MDR-TB burden countries in the world and falls behind neighboring countries in terms of the prevalence of the disease. The objective of this paper was to review the situation of tuberculosis and MDR-TB in Lithuania, and current available methods of treatment, control and diagnosis of this disease. |
| first_indexed | 2024-03-12T08:33:06Z |
| format | Article |
| id | doaj.art-a08f1187c142435ba42f7c15529a1705 |
| institution | Directory Open Access Journal |
| issn | 1010-660X |
| language | English |
| last_indexed | 2024-03-12T08:33:06Z |
| publishDate | 2016-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-a08f1187c142435ba42f7c15529a17052023-09-02T17:27:16ZengMDPI AGMedicina1010-660X2016-01-01522697810.1016/j.medici.2016.02.002Multidrug-resistant tuberculosis in Lithuania – Still a long way aheadGreta Musteikienė0Skaidrius Miliauskas1Raimundas Sakalauskas2Astra Vitkauskienė3Marius Žemaitis4Department of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Laboratory Medicine, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDespite the recent advances in the diagnosis of tuberculosis, treatment of the disease, for the most part, remains the same as it was half a century ago. In recent years only two new anti-tuberculosis drugs have been approved by the European Medicines Agency and Food and Drug Administration. Though the prevalence of this disease is slowly decreasing all over Europe, new challenges appear. One of them is multidrug-resistant tuberculosis (MDR-TB). This problem is especially prominent in Lithuania, which is one of the 27 high MDR-TB burden countries in the world and falls behind neighboring countries in terms of the prevalence of the disease. The objective of this paper was to review the situation of tuberculosis and MDR-TB in Lithuania, and current available methods of treatment, control and diagnosis of this disease.http://www.sciencedirect.com/science/article/pii/S1010660X16000203TuberculosisMultidrug-resistant tuberculosisExtensively drug-resistant tuberculosisAnti-tuberculosis drugs |
| spellingShingle | Greta Musteikienė Skaidrius Miliauskas Raimundas Sakalauskas Astra Vitkauskienė Marius Žemaitis Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead Medicina Tuberculosis Multidrug-resistant tuberculosis Extensively drug-resistant tuberculosis Anti-tuberculosis drugs |
| title | Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead |
| title_full | Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead |
| title_fullStr | Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead |
| title_full_unstemmed | Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead |
| title_short | Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead |
| title_sort | multidrug resistant tuberculosis in lithuania still a long way ahead |
| topic | Tuberculosis Multidrug-resistant tuberculosis Extensively drug-resistant tuberculosis Anti-tuberculosis drugs |
| url | http://www.sciencedirect.com/science/article/pii/S1010660X16000203 |
| work_keys_str_mv | AT gretamusteikiene multidrugresistanttuberculosisinlithuaniastillalongwayahead AT skaidriusmiliauskas multidrugresistanttuberculosisinlithuaniastillalongwayahead AT raimundassakalauskas multidrugresistanttuberculosisinlithuaniastillalongwayahead AT astravitkauskiene multidrugresistanttuberculosisinlithuaniastillalongwayahead AT mariuszemaitis multidrugresistanttuberculosisinlithuaniastillalongwayahead |